City of Hope Researchers Find “Achilles' Heel” in B Cell Tumors
March 14, 2018 | Katie Neith
In a new paper published in the journal Cell, a team of researchers led by City of Hope’s Markus Müschen, M.D., Ph.D., and Gang Xiao, Ph.D., reports on the discovery of a new therapeutic target for these B cell malignancies.
‘Goldilocks’ Therapies Could Be a Breakthrough for Patients with Lymphoma
March 6, 2018 | City of Hope
Thanks to research being done by City of Hope's Markus Müschen, M.D., Ph.D., lymphoma patients may soon receive treatments that leverage quality control mechanisms that our own immune systems utilize to fight harmful antibodies.
New Researcher Takes Aim at Acute Myeloid Leukemia
February 27, 2018 | City of Hope
Acute myeloid leukemia, or AML, is one of the most common and fatal forms of blood-related cancers. Jianjun Chen, Ph.D., a new faculty member at City of Hope, dedicates much of his research program to learning more about the disease.
Researchers discover sugar-addiction of cancer cells in childhood leukemia
July 10, 2017 | Katie Neith
According to a new article in Nature, a team led by City of Hope’s Markus Müschen, M.D., Ph.D., Chair of the Department of Systems Biology, thinks that sugar uptake and energy supply may play a key role in the relapse of ALL.
The Search for the Elephant Gene
July 5, 2017 | Michael Easterling
The African bull elephant is the largest mammal on the planet, comprised of trillions of cells that should ostensibly be a breeding ground for cancer. But because of an evolutionary anomaly, elephants don’t get cancer, a fact that fascinates Markus Müschen, M.D., Ph.D.
Markus Müschen, M.D., Ph.D., Is a Man on a Mission: Ending Childhood Leukemia
February 14, 2017 | Abe Rosenberg
Hailed as one of the best researchers of his generation, Markus Müschen, M.D., Ph.D., has joined City of Hope with the singular goal of wiping out Acute Lymphoblastic Leukemia (ALL), the most common form of cancer in children.